Health TrialsbyHealthPanel

Impact of Topical Aromatherapy on Postoperative Quality of Recovery After Lung Resection

ConditionsThoracic Surgical ProceduresPostoperative RecoveryPainComplementary TherapiesAromatherapy
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Hospital, Toulouse

About this trial

The key to early surgery recovery lies in optimal and immediate control of postoperative pain. Despite standard pain management protocols, lung resection is often associated with acute, neuropathic, or chronic pain, compounded by the side effects of morphine-based treatments. In this context, aromatherapy can provide complementary support, both to alleviate pain and to improve the quality of recovery after surgery.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adults aged 18 years or older,

undergoing scheduled lung resection for diagnostic or therapeutic purposes

able to give free, informed, signed consent (no later than the day of inclusion and before any examination required by the research)

person affiliated with or beneficiary of a social security system.

Disqualifiers

Patients with chronic pain prior to surgery

patients undergoing daily pain relief treatment prior to surgery

patients using essential oils applied to the skin for pain relief.

history of allergy to essential oils

Trial design

Design model

Parallel

Treatments tested in this trial

  • topical application of the "AromaQoR" formulation

    Other intervention

    topical application of the "AromaQoR" formulation, containing lavender essential oil (Lavandula angustifolia) diluted to 5% in sweet almond vegetable oil around the operated area

  • topical application of sweet almond vegetable oil

    Other intervention

    topical application of sweet almond oil around the operated area

Treatment groups

124 Participants
are divided into 2 treatment groups
Group A: PL =placeboPlacebo comparator 1 intervention
Group B: AT = aromatherapyExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Change in the total QoR-15F

Change in the total QoR-15F score (Recovery Quality score) on postoperative day 2 (measured in the evening, as it assesses, among other things, activity during the day) compared to the baseline value obtained the day before surgery, day -1, between the two groups.

Time frame
day 2

Secondary outcomes

1

Change in the total QoR-15F score (Recovery Quality) on postoperative Day 1 (evening)

Change in the total QoR-15F score (Recovery Quality) on postoperative D1 (evening) compared to the baseline value on Day-1

Time frame
Day 1
2

Change in the total QoR-15F score (Recovery Quality) on postoperative Day 3 (evening)

Change in the total QoR-15F score (Recovery Quality) on postoperative Day 3 (evening) compared to the baseline value on Day-1

Time frame
Day 3
3

Change in the total QoR-15F score 3 weeks after discharge (postoperative consultation)

Change in the total QoR-15F score 3 weeks after discharge (postoperative consultation) compared to the baseline value on D-1

Time frame
Week 3
4

Change in pain score at Day 0 (= day of surgery)

pain score measured by numerical scale (EN) at each measurement time point compared to Day-1

Time frame
Day 0

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University Hospital, Toulouse

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: